Description
Fischer Medical Ventures Limited will undergo a face value split from Rs. 10 to Re. 1 per share effective September 12, 2025.
Summary
The National Stock Exchange has announced that Fischer Medical Ventures Limited (FISCHER) will undergo a face value split from Rs. 10 to Re. 1 per equity share. This 10:1 split will be effective from September 12, 2025, increasing the number of shares while proportionally reducing the price per share.
Key Points
- Face value and paid-up value will change from Rs. 10 to Re. 1 per share
- The split ratio is 10:1 (each existing share will become 10 shares)
- No change in the total market capitalization or proportional ownership
- Trading with new face value begins September 12, 2025
Regulatory Changes
No regulatory changes are involved. This is a standard corporate action that adjusts the face value of existing equity shares while maintaining the same total capital structure.
Compliance Requirements
- Members must update their systems to reflect the new face value
- Ensure trading systems are configured for the split-adjusted shares from the effective date
- Update client records to reflect the increased number of shares post-split
Important Dates
- Circular Date: September 2, 2025
- Effective Date: September 12, 2025
- Trading with New Face Value: From September 12, 2025
Impact Assessment
The face value split will increase share liquidity by reducing the per-share price, making the stock more accessible to retail investors. Existing shareholders will receive 10 shares for every 1 share held, with no change in their proportional ownership or total investment value. Market systems and trading platforms will need to adjust for the new share count and price levels.
Impact Justification
Face value split is a routine corporate action that increases share liquidity without affecting market capitalization or investor holdings proportionally.